You just read:

Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis

News provided by

Maxwell Biotech Venture Fund

Mar 27, 2017, 09:00 ET